Researchers report that a combination of 3 medicinesaspirin, blood pressure-lowering beta-blockers, and cholesterol-lowering statinsmay more effectively improve the chances of survival for patients with heart disease than any of those taken alone. A study conducted at the University of Nottingham, England, showed that the combination resulted in an 83% reduction in deaths among these patients. The study is the first large-scale, long-term trial to find different drug combinations effective in the reduction of the risk of death in patients with heart disease. Experts have previously believed that a statin-aspirin-beta-blocker combination, along with folic acid, should be developed into a single pill that could be taken by all seniors 55 and older. Although the study suggests that such a pill could help patients with preexisting heart disease, there is no evidence to suggest that this pill should be prescribed for all seniors.
In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine
Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.
News from the year's biggest meetings
Clinical features with downloadable PDFs